Merck Investment in Capacity and Services

Merck Millipore, the Life Science Division of Merck has announced a €12 million capital investment in its Molsheim, France facility to increase its Ready-To-Use (RTU) Media manufacturing capabilities, better provide security of supplies for customers in the region and sustain the heipha/Hycon product lines including contact and settle plates (ICRplus plates) and Agar strips for RCS^® systems which are used in monitoring ambient air and compressed gases.

"We are committed to providing our customers with a reliable supply of products, including Ready-To-Use Media, which this investment in Molsheim will help to ensure," said Udit Batra, President and CEO of Merck Millipore. "Both Molsheim and heipha Eppelheim (Germany) sites will continue to support the increasing demand from our customers. This investment signifies our long-term dedication to Merck Millipore's Lab customers in this region and around the world."

This investment will result in expanded manufacturing capacity space, a new clean room, and two additional production lines similar to those existing in Eppelheim, where RTU Media will also continue to be manufactured. Research and development laboratories will also be centralised, forming an Innovation Centre to develop solutions for future customer needs said the company.